13 June 2018
Time: 17:00-18:30 CEST
In this presentation we introduce the relationship between the discovery phase and later clinical development. We discuss in some depth traditional clinical development pathways (tiers A and B) focusing on the non-inferiority trial design.
Watch the recording of the webinar
7 – 11 June 2018
Atlanta, United States
GARDP – workshop co-organizer on pre-clinical toxicology challenges
23 May 2018
Manica Balasegaram, Director, GARDP – keynote speaker at the event
22 May 2018
Event organized by GARDP and PLOS for the launch of the PLOS AMR Channel
Manica Balasegaram, Director GARDP – panel discussion and closing remarks
21-24 April 2018
Jean-Pierre Paccaud, Director of Business Development & Development Strategy – pipeline talk
GARDP – session co-organizer on expediting antibacterial development
Ursula Theuretzbacher, Founder and Director, Center for Anti-Infective Agents – session on GARDP
Magnus Unemo, Director, WHO Collaborating Centre for Gonorrhoea and other STIs – session on gonorrhoea
19-20 March, 2018
London, United Kingdom
Jean-Pierre Paccaud, Director of Business Development at GARDP – presentation of GARDP’s model
11-16 March 2018
Ventura, United States
Laura Piddock, Head of Scientific Affairs, GARDP – discussion leader for a session on antibacterial drug discovery and development
2 March 2018
Jean-Pierre Paccaud, Director of Business Development at GARDP – presentation on developments in the AMR field
29 January – 3 February 2018
Manica Balasegaram, Director of GARDP – stakeholder session
November 9-11, 2017
Cape Town, South Africa
Manica Balasegaram, Director of GARDP, presented at the event.
October 29-November 1, 2017
Santa Fe, USA
Giovanni Salerno, GARDP Head of Transversal Programmes, presented on the antibiotic memory recovery initiative.
X National Congress of Tropical Medicine and International Health
October 23-25, 2017
Representatives from DNDi and GARDP took part in the event.
September 6-8, 2017
Giovanni Salerno, Head of Transversal Programmes, GARDP, took part in the pre-conference workshop.
July 9-12, 2017
Rio de Janeiro, Brazil
Manica Balasegaram, GARDP’s Director, presented to and participated in, the round table at the event.
June 1-5, 2017
New Orleans, USA
Manica Balasegaram, GARDP’s Executive Director, presented on antibiotics at the event.
3-5 April, 2017
Jean-Pierre Paccaud, Business Development Director at Global Antibiotic R&D Partnership (GARDP), DNDi presented on antimicrobial resistance.
27-31 March, 2017
Director of GARDP, Manica Balasegaram, made a statement on behalf of the initiative.
7 December, 2016
New Delhi, India
Manica Balasegaram, Director and Jean Pierre Paccaud, Director of Business Development & Corporate Strategy at GARDP, and Suman RIjal, Head of the DNDi office in India, presented at the event.
1 September, 2016
Cape Town, South Africa
This one day gathering of 45 participants from 11 African countries aimed at advancing a collective understanding of and potential to address the most pressing antimicrobial-resistance (AMR)-related medical needs, research and development gaps, and collaboration opportunities in South Africa and other sub-Saharan countries.
2-3 August, 2016
A joint WHO-DNDi Global Antibiotic Research and Development Partnership (GARDP) event which was organized to review and evaluate an important NeoAMR proposal and to form a consensus on the way forward.